UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

The synuclein family

Genome research, 1998-09, Vol.8 (9), p.871

Lavedan, C

1998

Volltextzugriff (PDF)

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

The Lancet (British edition), 2015-10, Vol.386 (10005), p.1754-1764

2015

Volltextzugriff (PDF)

Tasimelteon: A selective and unique receptor binding profile

Neuropharmacology, 2015-04, Vol.91, p.142-147

2015

Volltextzugriff (PDF)

Absence of weight gain association with the HTR2C − 759C/T polymorphism in patients with schizophrenia treated with iloperidone

Psychiatry research, 2010-02, Vol.175 (3), p.271-273

2010

Volltextzugriff (PDF)

Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia

The journal of clinical psychiatry, 2009-06, Vol.70 (6), p.801

2009

Volltextzugriff (PDF)

Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia

Schizophrenia research, 2009-03, Vol.108 (1), p.134-142

2009

Volltextzugriff (PDF)

Mutation in the α-synuclein gene identified in families with Parkinson's disease

Science (American Association for the Advancement of Science), 1997-06, Vol.276 (5321), p.2045-2047

1997

Volltextzugriff (PDF)

Le tasimelteon entraîne l’horloge circadienne et procure une amélioration significative aux personnes totalement aveugles, souffrant du libre-cours

Médecine du sommeil, 2015-01, Vol.12 (1), p.55-56

2015

Volltextzugriff (PDF)

Identification, localization and characterization of the human γ-synuclein gene

Human genetics, 1998-07, Vol.103 (1), p.106-112

1998

Volltextzugriff (PDF)

Deletions in the Parkin gene and genetic heterogeneity in a greek family with early onset Parkinson's disease

Human genetics, 1998-10, Vol.103 (4), p.424-427

1998

Volltextzugriff (PDF)

Étude de sécurité, multicentrique, en ouvert, du tasimelteon pour le traitement du syndrome libre-cours chez les personnes totalement aveugles

Médecine du sommeil, 2015-01, Vol.12 (1), p.55

2015

Volltextzugriff (PDF)

A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration

Neuroscience letters, 2002-03, Vol.322 (1), p.57-61

2002

Volltextzugriff (PDF)

Myotonic dystrophy : size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism

American journal of human genetics, 1993-05, Vol.52 (5), p.875-883

1993

Volltextzugriff (PDF)

Long Uninterrupted CGG Repeats within the First Exon of the Human FMR1 Gene Are Not Intrinsically Unstable in Transgenic Mice

Genomics (San Diego, Calif.), 1998-06, Vol.50 (2), p.229-240

1998

Volltextzugriff (PDF)

Trinucleotide repeats (CGG) 22 TGG(CGG) 43 TGG(CGG) 21 from the fragile X gene remain stable in transgenic mice

Human genetics, 1997-08, Vol.100 (3-4), p.407-414

1997

Volltextzugriff (PDF)

Translating the Genome into individualized therapeutics

Drug development research, 2004-08, Vol.62 (4), p.371-382

2004

Volltextzugriff (PDF)

Genomic Organization and Expression of the Human β-Synuclein Gene (SNCB)

Genomics (San Diego, Calif.), 1998-11, Vol.54 (1), p.173-175

1998

Volltextzugriff (PDF)

Translating the genome into individualized therapeutics: R&D Activities Within Singapore's BioMedical Science Initiative

Drug development research, 2004, Vol.62 (4), p.371-382

2004

Volltextzugriff (PDF)

Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele

Human molecular genetics, 1993-08, Vol.2 (8), p.1263-1266

1993

Volltextzugriff (PDF)

Signing on to expression profiles

Nature genetics, 1999-11, Vol.23 (S3), p.42-42

1999

Volltextzugriff (PDF)

Mutation in the (alpha)-synuclein gene identified in families with Parkinson's disease

Science (American Association for the Advancement of Science), 1997-06, Vol.276 (5321), p.2045-2047

1997

Volltextzugriff (PDF)

Contig map of the Parkinson's disease region on 4q21-q23

DNA research, 1998-02, Vol.5 (1), p.19-23

1998

Volltextzugriff (PDF)

Mutation in the α-Synuclein Gene Indentified in Families with Parkinson's Disease

Science (American Association for the Advancement of Science), 1997-06, Vol.276 (5321), p.2045-2047

1997

Volltextzugriff (PDF)

What explains public transport use? Evidence from seven European cities

Transport policy, 2020-12, Vol.99, p.362-374

2020

Volltextzugriff (PDF)

Exposure to disinfection by-products in swimming pools and biomarkers of genotoxicity and respiratory damage – The PISCINA2 Study

Environment international, 2019-10, Vol.131, p.104988, Article 104988

2019

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The synuclein family

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

Tasimelteon: A selective and unique receptor binding profile

Absence of weight gain association with the HTR2C − 759C/T polymorphism in patients with schizophrenia treated with iloperidone

Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia

Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia

Mutation in the α-synuclein gene identified in families with Parkinson's disease

Le tasimelteon entraîne l’horloge circadienne et procure une amélioration significative aux personnes totalement aveugles, souffrant du libre-cours

Identification, localization and characterization of the human γ-synuclein gene

Deletions in the Parkin gene and genetic heterogeneity in a greek family with early onset Parkinson's disease

Étude de sécurité, multicentrique, en ouvert, du tasimelteon pour le traitement du syndrome libre-cours chez les personnes totalement aveugles

A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration

Myotonic dystrophy : size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism

Long Uninterrupted CGG Repeats within the First Exon of the Human FMR1 Gene Are Not Intrinsically Unstable in Transgenic Mice

Trinucleotide repeats (CGG) 22 TGG(CGG) 43 TGG(CGG) 21 from the fragile X gene remain stable in transgenic mice

Translating the Genome into individualized therapeutics

Genomic Organization and Expression of the Human β-Synuclein Gene (SNCB)

Translating the genome into individualized therapeutics: R&D Activities Within Singapore's BioMedical Science Initiative

Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele

Signing on to expression profiles

Mutation in the (alpha)-synuclein gene identified in families with Parkinson's disease

Contig map of the Parkinson's disease region on 4q21-q23

Mutation in the α-Synuclein Gene Indentified in Families with Parkinson's Disease

What explains public transport use? Evidence from seven European cities

Exposure to disinfection by-products in swimming pools and biomarkers of genotoxicity and respiratory damage – The PISCINA2 Study

Suchergebnisse filtern